GH Research PLC to Present at 37th ECNP Congress

Ticker: GHRS · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1855129

Gh Research PLC 6-K Filing Summary
FieldDetail
CompanyGh Research PLC (GHRS)
Form Type6-K
Filed DateSep 20, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: conference, presentation, R&D

TL;DR

GH Research PLC is going to a big science conference in Milan next week, presenting their latest research.

AI Summary

GH Research PLC announced its attendance at the 37th ECNP Congress in Milan, Italy, from September 21-24, 2024. The company will sponsor an industry mini-session and has attached a presentation by Wieslaw J. Cubala as Exhibit 99.1 to this filing.

Why It Matters

The company's participation in a major scientific congress signals potential advancements or updates in their research and development pipeline, which could impact investor sentiment and future stock performance.

Risk Assessment

Risk Level: low — This filing is an informational update about conference attendance and presentation, with no immediate financial or operational changes disclosed.

Key Players & Entities

FAQ

What is the purpose of GH Research PLC's attendance at the 37th ECNP Congress?

GH Research PLC will attend the 37th ECNP Congress to sponsor an industry mini-session and present research.

When and where is the 37th ECNP Congress taking place?

The Congress is scheduled to take place in Milan, Italy, between September 21 – 24, 2024.

Who will deliver the presentation during the industry mini-session?

Wieslaw J. Cubala will deliver the presentation during the industry mini-session.

What is attached to the filing as Exhibit 99.1?

A copy of the presentation prepared by Wieslaw J. Cubala to be delivered during the industry mini-session is attached as Exhibit 99.1.

Does GH Research PLC file annual reports under Form 20-F or Form 40-F?

GH Research PLC files annual reports under Form 20-F.

Filing Stats: 207 words · 1 min read · ~1 pages · Grade level 11.7 · Accepted 2024-09-20 07:00:25

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2024. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F GH Research PLC (the "Company") will attend the 37 th ECNP Congress, which is scheduled to take place in Milan, Italy between September 21 – 24, 2024 (the "Congress"). The Company will sponsor an industry mini session during the Congress. A copy of the presentation prepared by Wieslaw J. Cubala to be delivered during the industry mini session is attached hereto as Exhibit 99.1 . 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: September 20, 2024 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing